title: Regulation of immune responsiveness in vivo by disrupting an early T-cell signaling event using a cell-permeable peptide.
abstract: The inducible T cell kinase (ITK) regulates type 2 (Th2) cytokines that provide defense against certain parasitic and bacterial infections and are involved in the pathogenesis of lung inflammation such as allergic asthma. Activation of ITK requires the interaction of its SH3 domain with the poly-proline region of its signaling partner, the SH2 domain containing leukocyte phosphoprotein of 76 kilodaltons (SLP-76). The specific disruption of the ITK-SH3/SLP-76 poly-proline interaction in vitro by a cell-permeable competitive inhibitor peptide (R9-QQP) interferes with the activation of ITK and the transduction of its cellular functions in T lymphocytes. In the present investigation, we assessed the effects of R9-QQP treatment on the induction of an in vivo immune response as represented by lung inflammation in a murine model of allergic asthma. We found that mice treated with R9-QQP and sensitized and challenged with the surrogate allergen ovalbumin (OVA) display significant inhibition of lung inflammation in a peptide-specific manner. Thus, parameters of the allergic response, such as airway hyper-responsiveness, suppression of inflammatory cell infiltration, reduction of bronchial mucus accumulation, and production of relevant cytokines from draining lymph nodes were significantly suppressed. These findings represent the first demonstration of the biological significance of the interaction between ITK and SLP-76 in the induction of an immune response in a whole animal model and specifically underscore the significance of the ITK-SH3 domain interaction with the poly-proline region of SLP-76 in the development of an inflammatory response. Furthermore, the experimental approach of intracellular peptide-mediated inhibition might be applicable to the study of other important intracellular interactions thus providing a paradigm for dissecting signal transduction pathways.
authors.affiliation: Department of Biology and Center for Microbial Sciences, San Diego State University, San Diego, California, United States of America.
authors.forename: David M
authors.initials: DM
authors.lastname: Guimond
authors.forename: Nicholas R
authors.initials: NR
authors.lastname: Cam
authors.forename: Nupura
authors.initials: N
authors.lastname: Hirve
authors.forename: Wei
authors.initials: W
authors.lastname: Duan
authors.forename: John D
authors.initials: JD
authors.lastname: Lambris
authors.forename: Michael
authors.initials: M
authors.lastname: Croft
authors.forename: Constantine D
authors.initials: CD
authors.lastname: Tsoukas
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016535:Bronchial Hyperreactivity / Q000150:complications / Q000276:immunology / Q000473:pathology; D055745:Bronchioles / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D057846:Cell-Penetrating Peptides / Q000737:chemistry / Q000494:pharmacology*; D016207:Cytokines / Q000096:biosynthesis; D004802:Eosinophilia / Q000150:complications / Q000276:immunology / Q000473:pathology; D005260:Female; D020397:Goblet Cells / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D007109:Immunity / Q000187:drug effects*; D008198:Lymph Nodes / Q000473:pathology; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D009093:Mucus / Q000378:metabolism; D010047:Ovalbumin / Q000276:immunology; D011014:Pneumonia / Q000150:complications / Q000276:immunology / Q000473:pathology; D011505:Protein-Tyrosine Kinases; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology*; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology*
chemical_list: D057846:Cell-Penetrating Peptides; D016207:Cytokines; D010047:Ovalbumin; D011505:Protein-Tyrosine Kinases; C080813:emt protein-tyrosine kinase